Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Non-small Cell Lung Cancer · Solid Tumors

BioNTech SE

BioNTech SE trial registry — 23 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
An der Goldgrube 12, Mainz, Rhineland-Palatinate 55131, DE HQ
2008 Founded
5,119 Employees
NMPA registrant Type
Company details
Status
Public
HQ
An der Goldgrube 12, Mainz, Rhineland-Palatinate 55131, DE
Founded
2008
Employees
5,119
Programs
23
Drugs
35
Patents
25
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Trials

BioNTech SE clinical trials

Registry index of 23 ClinicalTrials.gov studies linked to BioNTech SE programs — each row shows trial ID, program name, phase, status, and indication.

BioNTech SE trial registry — 23 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for BioNTech SE.

  1. NTC-001 — Phase 1

    Clinical update

  2. BNT111-01 — Phase 2

    Clinical update

  3. BNT321-02 — Phase 2

    Clinical update

  4. BNT164-01 — Phase 1

    Clinical update

  5. BNT116-01 — Phase 1

    Clinical update

  6. BNT351-01 — Phase 1

    Clinical update

  7. BNT327-06 — Phase 3

    Clinical update

  8. BNT327-05 — Phase 3

    Clinical update

Trial registry

23 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.